Supernus Pharmaceuticals (SUPN) Invested Capital (2011 - 2023)
Supernus Pharmaceuticals' Invested Capital was $921.52 million in Q4 2023, down 28.5% from $1.29 billion a year earlier but up 1.0% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Invested Capital (2011 - 2023) Analysis & Trends
From Q4 2011 onward, Supernus Pharmaceuticals has reported Invested Capital for 14 quarters.
- In earlier years, Invested Capital was $1.29 billion in FY2022 (+7.8%) and $1.2 billion in FY2021.
- Quarterly Invested Capital has moved between $912.19 million (Q3 2023) and $1.39 billion (Q1 2023) over five years.
- Compared with a year earlier, Invested Capital has declined for three straight quarters, with an average decline of 18.5% over the last four quarters.
- Per Business Quant data, SUPN's Invested Capital in the three quarters before Q4 2023 was $912.19 million (Q3 2023), $919.91 million (Q2 2023) and $1.39 billion (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.50 Bn | 1.16 Bn | 185.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 921.52 Mn |
| Sep 30, 2023 | 912.19 Mn |
| Jun 30, 2023 | 919.91 Mn |
| Mar 31, 2023 | 1.39 Bn |
| Dec 31, 2022 | 1.29 Bn |
| Sep 30, 2022 | 1.25 Bn |
| Jun 30, 2022 | 1.24 Bn |
| Dec 31, 2021 | 1.20 Bn |
| Mar 31, 2013 | 61.38 Mn |
| Dec 31, 2012 | 80.47 Mn |
| Sep 30, 2012 | 50.24 Mn |
| Jun 30, 2012 | 65.79 Mn |
| Mar 31, 2012 | 29.37 Mn |
| Dec 31, 2011 | 38.93 Mn |
API Access
Supernus Pharmaceuticals Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();